Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 14, 2025
Date Accepted: Sep 9, 2025

The final, peer-reviewed published version of this preprint can be found here:

A Smartphone App (WExercise) to Promote Physical Activity Among Cancer Survivors: Randomized Controlled Trial

Cheung DST, Kwok TWH, Liu S, Rhodes RE, Chau PH, Chiang CL, Lee AWm, Lin CC

A Smartphone App (WExercise) to Promote Physical Activity Among Cancer Survivors: Randomized Controlled Trial

J Med Internet Res 2025;27:e75839

DOI: 10.2196/75839

PMID: 41042984

PMCID: 12494186

Effectiveness of a Smartphone Application for Promoting Physical Activity among Cancer Survivors (WExercise): A Randomized Controlled Trial

  • Denise Shuk Ting Cheung; 
  • Tiffany Wing Han Kwok; 
  • Sam Liu; 
  • Ryan E Rhodes; 
  • Pui Hing Chau; 
  • Chi-Leung Chiang; 
  • Anne Wing-mui Lee; 
  • Chia-Chin Lin

ABSTRACT

Background:

Cancer survivors encounter distinct health challenges. As a way of addressing these challenges, physical activity (PA) has emerged as a safe and recommended intervention. The multi-process action control (M–PAC) framework is a layered approach to behavior change and has been widely applied to promote PA. However, no randomized-controlled trial of technology-based interventions has been evaluated based on this framework. In view of this research gap, a smartphone application named WExercise was developed on the basis of M–PAC to promote PA of cancer survivors.

Objective:

To examine the effect of a smartphone application (WExercise) on physical activity promotion among cancer survivors.

Methods:

This study employs an assessor-blind two-arm randomized controlled trial. The intervention group used WExercise, which was developed based on the multi-process action control (M–PAC) framework. The control group received written physical activity recommendations. Outcomes examined include exercise behavior (primary), exercise capacity, quality of life, and M–PAC constructs.

Results:

Ninety-eight physically inactive cancer survivors who have completed curative treatment were recruited. Some 82.7% of participants remained in the study. For the primary outcome, i.e., physical activity, mixed findings were identified: ActiGraph-measured moderate-to-vigorous physical activity (MVPA) showed non-significant change for both groups (group×time interaction p=0.736), while self-reported MVPA showed significant improvement in the intervention group compared to the control group at both post-intervention (mean difference in change=106.95 minutes, p<.001) and 3 months post-intervention (mean difference in change=66.34 minutes, p<0.001) (group×time interaction p=0.003). WExercise also had significant effects on increasing cancer survivors’ exercise capacity, but not their quality of life or M–PAC constructs.

Conclusions:

WExercise demonstrated a significant effect in increasing self-reported physical activity, but it was not corroborated with ActiGraph-measured physical activity. Further research is needed to look into the discrepancy between the self-reported and objective data. Clinical Trial: ClinicalTrials.gov ID NCT05631587


 Citation

Please cite as:

Cheung DST, Kwok TWH, Liu S, Rhodes RE, Chau PH, Chiang CL, Lee AWm, Lin CC

A Smartphone App (WExercise) to Promote Physical Activity Among Cancer Survivors: Randomized Controlled Trial

J Med Internet Res 2025;27:e75839

DOI: 10.2196/75839

PMID: 41042984

PMCID: 12494186

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.